PDE4B-IN-3
PDE4B-IN-3 is a potent PDE4B inhibitor with an IC50 of 0.94 μM. PDE4B-IN-3 has anti-inflammatory activities[1].
Product Specifications
CAS Number
2819779-01-4
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/pde4b-in-3.html
Purity
99.37
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
CC(C1=CC(C(C)C)=C(C(C(C)C)=C1)S(=O)(NC2=CC(NS(=O)(C3=CC=CC4=CC=CN=C43)=O)=CC=C2)=O)C
Molecular Formula
C30H35N3O4S2
Molecular Weight
565.75
References & Citations
[1]Siqi Xing, et al. Novel quinoline-based derivatives: A new class of PDE4B inhibitors for adjuvant-induced arthritis. Eur J Med Chem. 2022 Aug 5;238:114497.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PDE4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742027-500 1x 500 µL
CD45 / LCA (Leucocyte Marker) (PTPRC/1147 + PTPRC/1460), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LY427764 100 µg
Annexin A2 (ANXA2) (NM_001136015) Human Over-expression Lysate
Sign In for Pricing
View Details 
TRC-E932270-2.5MG 2.5 mg
(17Alpha)-3-Ethynyl-19-norpregna-3,5-dien-20-yn-17-ol
Sign In for Pricing
View Details 